Testosterone transdermal - Pierre FabreAlternative Names: Testopatch
Latest Information Update: 05 Apr 2015
At a glance
- Originator Pierre Fabre
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone congener stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypogonadism
Most Recent Events
- 15 Mar 2016 Biomarkers information updated